Published in Lancet on December 19, 1987
Three decades of beta-lactamase inhibitors. Clin Microbiol Rev (2010) 5.54
Mutation frequencies and antibiotic resistance. Antimicrob Agents Chemother (2000) 3.27
Characterization of a new TEM-type beta-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coli. Antimicrob Agents Chemother (1993) 2.34
Discriminatory detection of inhibitor-resistant beta-lactamases in Escherichia coli by single-strand conformation polymorphism-PCR. Antimicrob Agents Chemother (1998) 1.88
Epidemiological survey of amoxicillin-clavulanate resistance and corresponding molecular mechanisms in Escherichia coli isolates in France: new genetic features of bla(TEM) genes. Antimicrob Agents Chemother (2000) 1.83
Predictive analysis of transmissible quinolone resistance indicates Stenotrophomonas maltophilia as a potential source of a novel family of Qnr determinants. BMC Microbiol (2008) 1.59
Transferable hyperproduction of TEM-1 beta-lactamase in Shigella flexneri due to a point mutation in the pribnow box. Antimicrob Agents Chemother (1997) 1.55
Acquired resistance of Nocardia brasiliensis to clavulanic acid related to a change in beta-lactamase following therapy with amoxicillin-clavulanic acid. Antimicrob Agents Chemother (1991) 1.48
Resistance to cefoperazone-sulbactam in Klebsiella pneumoniae: evidence for enhanced resistance resulting from the coexistence of two different resistance mechanisms. Antimicrob Agents Chemother (1993) 1.19
SmQnr contributes to intrinsic resistance to quinolones in Stenotrophomonas maltophilia. Antimicrob Agents Chemother (2009) 1.09
The intrinsic resistome of bacterial pathogens. Front Microbiol (2013) 1.05
In vitro selection of variants resistant to beta-lactams plus beta-lactamase inhibitors in CTX-M beta-lactamases: predicting the in vivo scenario? Antimicrob Agents Chemother (2011) 1.04
Ampicillin-sulbactam and amoxicillin-clavulanate susceptibility testing of Escherichia coli isolates with different beta-lactam resistance phenotypes. Antimicrob Agents Chemother (1999) 0.99
Efficacy of ampicillin-sulbactam versus that of cefoxitin for treatment of Escherichia coli infections in a rat intra-abdominal abscess model. Antimicrob Agents Chemother (1993) 0.95
Biochemical characterization of CTX-M-15 from Enterobacter cloacae and designing a novel non-β-lactam-β-lactamase inhibitor. PLoS One (2013) 0.91
Emergence and spread of antibiotic resistance: setting a parameter space. Ups J Med Sci (2014) 0.90
Molecular epidemiology of the plasmid-encoded TEM-1 beta-lactamase in Scotland. Epidemiol Infect (1993) 0.89
Detection of resistance to beta-lactamase inhibitors in strains with CTX-M beta-lactamases: a multicenter external proficiency study using a well-defined collection of Escherichia coli strains. J Clin Microbiol (2013) 0.83
A naturally occurring SNP in plasmid pB1000 produces a reversible increase in antibiotic resistance. Antimicrob Agents Chemother (2016) 0.75
Comparative genomics of Listeria species. Science (2001) 12.94
High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science (2000) 9.14
Expression in Escherichia coli and sequence analysis of the listeriolysin O determinant of Listeria monocytogenes. Infect Immun (1988) 6.74
Listeriolysin O is essential for virulence of Listeria monocytogenes: direct evidence obtained by gene complementation. Infect Immun (1989) 5.04
Complex clonal and plasmid epidemiology in the first outbreak of Enterobacteriaceae infection involving VIM-1 metallo-beta-lactamase in Spain: toward endemicity? Clin Infect Dis (2007) 4.51
Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill (2008) 4.03
Mutation frequencies and antibiotic resistance. Antimicrob Agents Chemother (2000) 3.27
Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect (2008) 3.18
Gene sequence and biochemical characterization of FOX-1 from Klebsiella pneumoniae, a new AmpC-type plasmid-mediated beta-lactamase with two molecular variants. Antimicrob Agents Chemother (1994) 3.09
Nucleotide sequence and characterization of a novel cefotaxime-hydrolyzing beta-lactamase (CTX-M-10) isolated in Spain. Antimicrob Agents Chemother (2001) 2.91
Microcin plasmids: a group of extrachromosomal elements coding for low-molecular-weight antibiotics in Escherichia coli. J Bacteriol (1978) 2.83
Antibiotics as intermicrobial signaling agents instead of weapons. Proc Natl Acad Sci U S A (2006) 2.80
Mycobacterium tuberculosis subsp. caprae subsp. nov.: a taxonomic study of a new member of the Mycobacterium tuberculosis complex isolated from goats in Spain. Int J Syst Bacteriol (1999) 2.63
A gene conferring resistance to vancomycin but not teicoplanin in isolates of Enterococcus faecalis and Enterococcus faecium demonstrates homology with vanB, vanA, and vanC genes of enterococci. Antimicrob Agents Chemother (1993) 2.56
Vancomycin-resistant Enterococcus faecium in hospitalized children. Infect Control Hosp Epidemiol (1992) 2.46
Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain. Antimicrob Agents Chemother (2001) 2.42
Characterization of a new TEM-type beta-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coli. Antimicrob Agents Chemother (1993) 2.34
Induction of the SOS response by new 4-quinolones. J Antimicrob Chemother (1987) 2.31
Phenotypic tolerance: antibiotic enrichment of noninherited resistance in bacterial populations. Antimicrob Agents Chemother (2005) 2.20
Comparative study of mupirocin and oral co-trimoxazole plus topical fusidic acid in eradication of nasal carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1995) 2.14
Factors determining resistance to beta-lactam combined with beta-lactamase inhibitors in Escherichia coli. J Antimicrob Chemother (1991) 2.12
Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals. Antimicrob Agents Chemother (2007) 2.04
New extended-spectrum TEM-type beta-lactamase from Salmonella enterica subsp. enterica isolated in a nosocomial outbreak. Antimicrob Agents Chemother (1995) 1.99
Transmission between HIV-infected patients of multidrug-resistant tuberculosis caused by Mycobacterium bovis. AIDS (1997) 1.98
European recommendations for antimicrobial resistance surveillance. Clin Microbiol Infect (2004) 1.95
Plasmids in Listeria. Plasmid (1982) 1.94
Prevalence of Leishmania infection among AIDS patients. Lancet (1992) 1.93
Visceral leishmaniasis in patients infected with human immunodeficiency virus (HIV). Ann Intern Med (1989) 1.82
Evaluation of a new system, VITEK 2, for identification and antimicrobial susceptibility testing of enterococci. J Clin Microbiol (2000) 1.78
In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia. Antimicrob Agents Chemother (2001) 1.74
Outbreak of a multiresistant Klebsiella pneumoniae strain in an intensive care unit: antibiotic use as risk factor for colonization and infection. Clin Infect Dis (2000) 1.74
Genetic characterization of multidrug-resistant Mycobacterium bovis strains from a hospital outbreak involving human immunodeficiency virus-positive patients. J Clin Microbiol (1997) 1.72
Streptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolide and beta-lactam consumption in Spain (1979-1997). J Antimicrob Chemother (2000) 1.72
vanA-mediated vancomycin-resistant Enterococcus spp. in sewage. J Antimicrob Chemother (1994) 1.71
Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase. J Med Chem (1998) 1.70
Multiply antibiotic-resistant Streptococcus pneumoniae recovered from Spanish hospitals (1988-1994): novel major clones of serotypes 14, 19F and 15F. Microbiology (1996) 1.69
Allele-specific PCR method based on pncA and oxyR sequences for distinguishing Mycobacterium bovis from Mycobacterium tuberculosis: intraspecific M. bovis pncA sequence polymorphism. J Clin Microbiol (1998) 1.66
Antibiotic resistance in Campylobacter strains isolated from animals, foods, and humans in Spain in 1997-1998. Antimicrob Agents Chemother (2000) 1.64
Evaluation of the Wider system, a new computer-assisted image-processing device for bacterial identification and susceptibility testing. J Clin Microbiol (2000) 1.62
Some aspects of human and canine macroscopic pancreas innervation. Am J Gastroenterol (1976) 1.57
Concentration-dependent selection of small phenotypic differences in TEM beta-lactamase-mediated antibiotic resistance. Antimicrob Agents Chemother (2000) 1.55
Expression of multidrug efflux pump SmeDEF by clinical isolates of Stenotrophomonas maltophilia. Antimicrob Agents Chemother (2001) 1.53
International collaborative study on standardization of bacterial sensitivity to fosfomycin. J Antimicrob Chemother (1983) 1.52
Hepatitis E virus: relevance in blood donors and other risk groups. Vox Sang (1998) 1.51
Biological cost of AmpC production for Salmonella enterica serotype Typhimurium. Antimicrob Agents Chemother (2000) 1.50
Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986-1997). J Antimicrob Chemother (2000) 1.48
Macrolide resistance genes in Enterococcus spp. Antimicrob Agents Chemother (2000) 1.48
Postantibiotic effect of imipenem on gram-positive and gram-negative micro-organisms. J Antimicrob Chemother (1986) 1.46
Mechanisms of iron acquisition and bacterial virulence. FEMS Microbiol Rev (1990) 1.44
In vitro activity of linezolid against Mycobacterium tuberculosis complex, including multidrug-resistant Mycobacterium bovis isolates. Int J Antimicrob Agents (2006) 1.42
Do bacteria have sex? Nature (1991) 1.42
The emergence of highly fluoroquinolone-resistant Escherichia coli in community-acquired urinary tract infections. J Antimicrob Chemother (1992) 1.40
beta-Lactam coselection of sensitive and TEM-1 beta-lactamase-producing subpopulations in heterogeneous Escherichia coli colonies. J Antimicrob Chemother (1985) 1.40
Single amino acid replacements at positions altered in naturally occurring extended-spectrum TEM beta-lactamases. Antimicrob Agents Chemother (1995) 1.40
An extended-spectrum AmpC-type beta-lactamase obtained by in vitro antibiotic selection. FEMS Microbiol Lett (1998) 1.40
Giant magnetoresistance in ferromagnet/superconductor superlattices. Phys Rev Lett (2005) 1.39
Metronidazole resistance in Clostridium difficile is heterogeneous. J Clin Microbiol (2008) 1.38
Role of universal 16S rRNA gene PCR and sequencing in diagnosis of prosthetic joint infection. J Clin Microbiol (2011) 1.37
Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence. J Antimicrob Chemother (2002) 1.37
Healthcare-associated infections: think globally, act locally. Clin Microbiol Infect (2008) 1.35
Escherichia coli and Staphylococcus aureus: bad news and good news from the European Antimicrobial Resistance Surveillance Network (EARS-Net, formerly EARSS), 2002 to 2009. Euro Surveill (2011) 1.34
Susceptibility of Streptococcus pneumoniae to penicillin: a prospective microbiological and clinical study. Clin Infect Dis (1992) 1.34
Small plasmids are involved in amoxicillin-clavulanate resistance in Escherichia coli. Antimicrob Agents Chemother (1989) 1.31
Implication of Ile-69 and Thr-182 residues in kinetic characteristics of IRT-3 (TEM-32) beta-lactamase. Antimicrob Agents Chemother (1996) 1.30
Long-term persistence of ciprofloxacin-resistant Haemophilus influenzae in patients with cystic fibrosis. J Infect Dis (1996) 1.29
Serotypes, Clones, and Mechanisms of Resistance of Erythromycin-Resistant Streptococcus pneumoniae Isolates Collected in Spain. Antimicrob Agents Chemother (2007) 1.28
Correlation between in vitro resistance to fluconazole and clinical outcome of oropharyngeal candidiasis in HIV-infected patients. Eur J Clin Microbiol Infect Dis (1996) 1.28
Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients. Clin Microbiol Infect (2005) 1.27
Selection of naturally occurring extended-spectrum TEM beta-lactamase variants by fluctuating beta-lactam pressure. Antimicrob Agents Chemother (2000) 1.27
Multicentre evaluation of the VITEK 2 Advanced Expert System for interpretive reading of antimicrobial resistance tests. J Antimicrob Chemother (2002) 1.25
Genetics of oxacillin resistance in clinical isolates of Streptococcus pneumoniae that are oxacillin resistant and penicillin susceptible. Antimicrob Agents Chemother (1994) 1.25
Penicillin-binding protein 3 of Listeria monocytogenes as the primary lethal target for beta-lactams. Antimicrob Agents Chemother (1990) 1.25
Antimicrobial susceptibilities of unique Stenotrophomonas maltophilia clinical strains. Antimicrob Agents Chemother (2001) 1.24
Group-C beta-hemolytic streptococcal bacteremia. Diagn Microbiol Infect Dis (1992) 1.22
Soft salt-mannitol agar-cloxacillin test: a highly specific bedside screening test for detection of colonization with methicillin-resistant Staphylococcus aureus. J Clin Microbiol (1998) 1.22
A237T as a modulating mutation in naturally occurring extended-spectrum TEM-type beta-lactamases. Antimicrob Agents Chemother (1998) 1.22
Stenotrophomonas maltophilia in cystic fibrosis patients. Eur J Clin Microbiol Infect Dis (1995) 1.21
Pseudomonas aeruginosa: a survey of resistance in 136 hospitals in Spain. The Spanish Pseudomonas aeruginosa Study Group. Antimicrob Agents Chemother (1999) 1.20
Evidence to support the rationale that bacterial eradication in respiratory tract infection is an important aim of antimicrobial therapy. J Antimicrob Chemother (2001) 1.18
A model for whiplash. J Biomech (1968) 1.18
Leuconostoc species as a cause of bacteremia: two case reports and a literature review. Eur J Clin Microbiol Infect Dis (1991) 1.17
Characterization of a nosocomial outbreak involving an epidemic plasmid encoding for TEM-27 in Salmonella enterica subspecies enterica serotype Othmarschen. J Infect Dis (1996) 1.17
Group A streptococcal bacteremia. A 10-year prospective study. Medicine (Baltimore) (1997) 1.16
In vitro activity of the new glycopeptide LY333328 against multiply resistant gram-positive clinical isolates. Antimicrob Agents Chemother (1998) 1.15
Leptotrichia buccalis bacteremia in neutropenic children. J Clin Microbiol (1985) 1.12
Quinolone resistance by mutations in chromosomal gyrase genes. Just the tip of the iceberg? J Antimicrob Chemother (1998) 1.12
Mutations in 23S rRNA in Helicobacter pylori conferring resistance to erythromycin do not always confer resistance to clarithromycin. Antimicrob Agents Chemother (1999) 1.11
In vitro selective antibiotic concentrations of beta-lactams for penicillin-resistant Streptococcus pneumoniae populations. Antimicrob Agents Chemother (1994) 1.11
The complexed structure and antimicrobial activity of a non-beta-lactam inhibitor of AmpC beta-lactamase. Protein Sci (1999) 1.11
Rewarding properties of beta-endorphin as measured by conditioned place preference. Psychopharmacology (Berl) (1987) 1.11
A multidrug efflux transporter in Listeria monocytogenes. FEMS Microbiol Lett (2000) 1.10
H-NS and RpoS regulate emergence of Lac Ara+ mutants of Escherichia coli MCS2. J Bacteriol (1997) 1.09
Beta-lactam stability in frozen microdilution PASCO MIC panels using strains with known resistance mechanisms as biosensors. Diagn Microbiol Infect Dis (1996) 1.09
Indirect xenodiagnosis of visceral leishmaniasis in 10 HIV-infected patients using colonized Phlebotomus perniciosus. AIDS (1994) 1.09
Improved method of determining the susceptibility of Candida albicans to fluconazole. J Antimicrob Chemother (1995) 1.08